Juan Lacalzada-Almeida1, María Manuela Izquierdo-Gómez1, Javier García-Niebla2, Roberto Elosua3,4, Alejandro Jiménez-Sosa5, Adrian Baranchuk6, Antonio Bayes de Luna7. 1. Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain. 2. Servicios Sanitarios del Área de Salud de El Hierro, Valle del Golfo Health Center, El Hierro, Spain. 3. Cardiovascular Epidemiology and Genetics Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Catalonia, Spain. 4. Facultad de Medicina, CIBER Cardiovascular Diseases (CIBERCV), Universidad de Vic-Central de Cataluña, Vic, Spain. 5. Research Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain. 6. Heart Rhythm Service, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada. 7. Fundación Investigación Cardiovascular, Institut Català Ciències Cardiovasculars, Barcelona, Catalonia, Spain.
Abstract
BACKGROUND: The association between advanced interatrial block (aIAB) and atrial fibrillation (AF) is known as "Bayes' Syndrome." There is little information on the prognostic role that new speckle tracking echocardiographic (STE) imaging techniques could play in it. We have examined the relationship between left atrial (LA) STE and the prediction of new-onset AF and/or stroke in IAB patients. METHODS: This is an observational prospective and unicentric cohort study with 98 outpatients: 55 (56.2%) controls with normal ECG without IAB, 21 (21.4%) with partial IAB (pIAB) and 22 (22.4%) with aIAB. The end point was new-onset AF, ischemic stroke and the composite of both. RESULTS: During a mean follow-up of 1.9 (1.7-2.3) years, 20 patients presented the end point (18 new-onset AF and two strokes): 8 (14.5%) in the control group, 3 (14.3%) in pIAB and 9 (40.9%) in aIAB, p = 0.03. In multivariable comprehensive Cox regression analyses, a decrease in absolute value of strain rate during the booster pump function phase (SRa) was the only variable independently related to the appearance in the evolution of the end point, in the first model (age, P-wave duration and SRa): HR 19.9 (95% CI, 3.12-127.5), p = 0.002 and in the second (age, presence of aIAB and SRa): HR 24.2 (95% CI, 3.15-185.4), p = 0.002. CONCLUSIONS: In patients with IAB, a decrease in absolute value of LA SRa with STE predicts new-onset AF and ischemic stroke. Future studies should confirm our results and assess the prognostic usefulness of LA STE in patients with IAB.
BACKGROUND: The association between advanced interatrial block (aIAB) and atrial fibrillation (AF) is known as "Bayes' Syndrome." There is little information on the prognostic role that new speckle tracking echocardiographic (STE) imaging techniques could play in it. We have examined the relationship between left atrial (LA) STE and the prediction of new-onset AF and/or stroke in IAB patients. METHODS: This is an observational prospective and unicentric cohort study with 98 outpatients: 55 (56.2%) controls with normal ECG without IAB, 21 (21.4%) with partial IAB (pIAB) and 22 (22.4%) with aIAB. The end point was new-onset AF, ischemic stroke and the composite of both. RESULTS: During a mean follow-up of 1.9 (1.7-2.3) years, 20 patients presented the end point (18 new-onset AF and two strokes): 8 (14.5%) in the control group, 3 (14.3%) in pIAB and 9 (40.9%) in aIAB, p = 0.03. In multivariable comprehensive Cox regression analyses, a decrease in absolute value of strain rate during the booster pump function phase (SRa) was the only variable independently related to the appearance in the evolution of the end point, in the first model (age, P-wave duration and SRa): HR 19.9 (95% CI, 3.12-127.5), p = 0.002 and in the second (age, presence of aIAB and SRa): HR 24.2 (95% CI, 3.15-185.4), p = 0.002. CONCLUSIONS: In patients with IAB, a decrease in absolute value of LA SRa with STE predicts new-onset AF and ischemic stroke. Future studies should confirm our results and assess the prognostic usefulness of LA STE in patients with IAB.
Authors: Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner Journal: J Am Soc Echocardiogr Date: 2016-04 Impact factor: 5.251
Authors: Manuel Martínez-Sellés; Ignacio Fernández Lozano; Adrian Baranchuk; Antoni Bayes-Genis; Antonio Bayés de Luna Journal: Rev Esp Cardiol (Engl Ed) Date: 2016-03-02
Authors: Albert Massó-van Roessel; Luis Alberto Escobar-Robledo; Irene R Dégano; María Grau; Joan Sala; Rafel Ramos; Jaume Marrugat; Antoni Bayés de Luna; Roberto Elosua Journal: Rev Esp Cardiol (Engl Ed) Date: 2017-03-18
Authors: Luis Alberto Escobar-Robledo; Antoni Bayés-de-Luna; Josep Lupón; Adrian Baranchuk; Pedro Moliner; Manuel Martínez-Sellés; Elisabet Zamora; Marta de Antonio; Mar Domingo; Germán Cediel; Julio Núñez; Evelyn Santiago-Vacas; Antoni Bayés-Genís Journal: Int J Cardiol Date: 2018-05-18 Impact factor: 4.164
Authors: Juan Lacalzada-Almeida; María Manuela Izquierdo-Gómez; Carima Belleyo-Belkasem; Patricia Barrio-Martínez; Javier García-Niebla; Roberto Elosua; Alejandro Jiménez-Sosa; Luis Alberto Escobar-Robledo; Antonio Bayés de Luna Journal: BMC Cardiovasc Disord Date: 2018-02-21 Impact factor: 2.298
Authors: Wesley T O'Neal; Zhu-Ming Zhang; Laura R Loehr; Lin Y Chen; Alvaro Alonso; Elsayed Z Soliman Journal: Am J Cardiol Date: 2016-03-18 Impact factor: 2.778
Authors: Luisa Ciuffo; Vanesa Bruña; Manuel Martínez-Sellés; Henrique Doria de Vasconcellos; Susumu Tao; Tarek Zghaib; Saman Nazarian; David D Spragg; Joseph Marine; Ronald D Berger; Joao A C Lima; Hugh Calkins; Antonio Bayés-de-Luna; Hiroshi Ashikaga Journal: J Cardiovasc Electrophysiol Date: 2020-06-15